glucagon has been researched along with Liver Cirrhosis in 228 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 152 (66.67) | 18.7374 |
| 1990's | 51 (22.37) | 18.2507 |
| 2000's | 14 (6.14) | 29.6817 |
| 2010's | 7 (3.07) | 24.3611 |
| 2020's | 4 (1.75) | 2.80 |
| Authors | Studies |
|---|---|
| Feigh, M; Harris, MS; Nestor, JJ; Parkes, D; Suschak, JJ | 1 |
| Bandholm, T; Hansen, AE; Jespersen, S; Krogh-Madsen, R; Madsbad, S; Pedersen, BK; Plomgaard, P; Ritz, C; Weis, N | 1 |
| Ambelil, M; Basu Mallick, A; DiMeglio, M; Ganetzky, R; Giri, VN; Halegoua-DeMarzio, D; Lavu, H; Lefler, DS; Maley, W; Miller, J; Robbins, J; Sato, T; Shah, AP; Vijayvergia, N; Yu, R | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Chen, C; Chen, X; Chen, Y; Lin, Z; Lu, Y; Wan, H; Wang, C; Wang, N; Wang, Y; Xia, F; Zhang, W | 1 |
| Gluud, LL; Pedersen, BK; Plomgaard, P; Rinnov, AR | 1 |
| Borovoy, J; Guevara, RL; Kershenobich, D | 1 |
| Brabosa, W; Curvêlo, LA; Ferrari, AP; Kondo, M; Lanzoni, V; Parise, ER; Rhor, R | 1 |
| Grønbaek, H; Holland-Fischer, P; Mengel, A; Nielsen, MF; Schmitz, O; Tønner-Nielsen, D; Vilstrup, H | 1 |
| Babu, SR; Cao, SS; Da Zhang, Z; Hu, T; Hu, WM; Le Tian, B; Su, AP; Wang, ZL; Zhang, Y | 1 |
| Dejong, CH; Deutz, N; Hayes, PC; Jalan, R; Mpabanzi, L; Olde Damink, SW | 1 |
| Brabant, G; Gläser, S; Kasim, E; Kroencke, T; Lochs, H; Ockenga, J; Omar, A; Schuetz, T; Schulzke, JD; Tietge, UJ; Valentini, L | 1 |
| Abe, M; Akiba, J; Kage, M; Kawaguchi, T; Kawahara, A; Koga, H; Sakata, M; Sata, M; Taira, T; Taniguchi, E | 1 |
| Jiao, J; Wang, G; Wang, JB; Zhang, AG; Zhao, P | 1 |
| Hu, PJ; Lin, LL; Wu, BF | 1 |
| DANOWSKI, TS; FERGUS, EB; GILLESPIE, HK; PUNTERERI, AJ | 1 |
| BUTTERFIELD, WJ; EL-GHALID, A; GHANEM, MH; HABBIB, M; SAID, M | 1 |
| CESANO, L; CHIANDUSSI, L; FERUGLIO, FS; GRECO, F; INDOVINA, D; MURATORI, F; SARDI, G; VACCARINO, A | 1 |
| KELLEY, VC; RUVALCABA, RH; SAMOLS, E | 1 |
| LEEVY, CM | 1 |
| CESANO, L; CHIANDUSSI, L; FERUGLIO, FS; GAGNA, C; GRECO, F; PUPITA, F; SARDI, G; SARTORIS, S | 1 |
| CESANO, L; CHIANDUSSI, L; COLONGO, PG; FERUGLIO, FS; GRECO, F; RAMELLO, A; SARDI, G | 1 |
| Jahoor, F; Shangraw, RE | 1 |
| Cao, JM; Han, JM; Li, JS; Wu, XJ; Yang, JF | 1 |
| Chang, FY; Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lin, HC; Yang, YY | 1 |
| Buchwald, A; Nolte, W; Raddatz, D; Ramadori, G; Rossbach, C; Scholz, KH | 1 |
| Paraf, A; Rautureau, J; Texier, J | 1 |
| Altomonte, L; Bertoli, A; Ghirlanda, G; Greco, AV; Manna, R; Rebuzzi, AG | 2 |
| Crespo Pinilla, J; Fermoso García, J; González Sarmiento, E | 1 |
| Burckhardt, D; Keller, U; Perruchoud, A; Sonnenberg, GE | 1 |
| Mourelle, M; Rojkind, M; Rubalcava, B | 1 |
| Gali, P; Hartmann, L | 1 |
| Honma, M; Maekubo, H; Matsushima, T; Okada, F; Ui, M | 1 |
| Fujisaki, K; Hashimoto, S; Kamibeppu, A; Nagahama, J; Tsubouchi, H | 1 |
| Amoruso, A; Francavilla, A; Ierardi, E; Sansonno, D | 1 |
| Ho, PW; Teng, CS; Yeung, RT | 1 |
| Allgayer, H; Hepp, KD | 1 |
| Bianchi, G; Bua, V; Dondi, C; Forlani, G; Marchesini, G; Melli, A; Pisi, E; Vannini, P; Zoli, M | 1 |
| Eisenstein, AB; Kabadi, UM; Uddinn, MS | 1 |
| Eisenstein, AB; Kabadi, UM; Pellicone, J; Tucci, J | 1 |
| Kako, M; Kanai, K; Kanno, T; Masaka, M; Morioka, S; Nakajima, T; Sudo, K; Yoshimi, T | 1 |
| Hasumura, Y; Hattori, K; Takeuchi, J | 1 |
| Avogaro, A; de Kreutzenberg, S; Duner, E; Gatta, A; Marescotti, C; Merkel, C; Mollo, F; Nosadini, R; Tiengo, A; Zuin, R | 1 |
| Fujiwara, M; Hayashi, S; Kobayashi, M; Nagashima, H; Nakatsukasa, H; Shiota, T; Takei, N; Watanabe, A; Yamauchi, Y | 1 |
| Higashi, T; Kumagae, T; Morishita, Y; Shimokawa, S; Taira, A; Umebayashi, Y; Yuda, T | 1 |
| Fujiwara, M; Kobayashi, M; Nagashima, H; Nakatsukasa, H; Shiota, T; Takei, N; Watanabe, A; Yamauchi, Y | 1 |
| Hayashi, S; Nagashima, H; Shiota, T; Watanabe, A | 1 |
| Bonora, E; Capretti, L; Pezzarossa, A; Speroni, G | 1 |
| Bratusch-Marrain, P; Ferenci, P; Korn, A; Nowotny, P; Waldhäusl, WK | 1 |
| Daikuhara, Y; Fujisaki, K; Gohda, E; Hashimoto, S; Hirono, S; Kamibeppu, A; Miyazaki, H; Nagahama, J; Oka, H; Tsubouchi, H | 1 |
| Tsubouchi, H | 2 |
| Balikó, Z; Lovász, E; Muth, L; Pasztarak, E; Tornóczky, J; Tóth, A; Tóth, G | 1 |
| Hayashi, S; Higashi, T; Nagashima, H; Obata, T; Sakata, T; Shiota, T; Takei, N; Watanabe, A | 1 |
| Kobayashi, T; Nihei, J; Ohneda, A; Sakai, T | 2 |
| Betancor, P; Carrillo, A; Font de Mora, A; Franic, L; Larrodera, L; Sosa, M | 1 |
| Burcharth, F; Holst, JJ; Kühl, C | 1 |
| Alford, FP; Dudley, FJ; Proietto, J | 1 |
| Gragnoli, G; Signorini, AM; Tanganelli, I | 2 |
| Anzai, T; Fujishima, A; Fujita, H; Hosokawa, Y; Kinoshita, H; Saito, M; Shirai, Y; Suga, M; Yokoyama, Y | 1 |
| Alberti, KG; Johnston, DG; Piniewska-Hulas, M; Whittaker, J | 1 |
| Bockel, R; Doffoël, M; Imler, M; Marescarux, J; Raul, F; Schlienger, JL; Zarski, JP | 1 |
| Altomonte, L; Bertoli, A; Ghirlanda, G; Greco, AV; Manna, R; Modugno, I; Palumbo, P | 1 |
| Alberti, KG; Binder, C; Faber, OK; Johnston, DG; Orskov, H; Wright, R | 1 |
| Bel, A; Girard, D | 1 |
| Angiolini, A; Dondi, C; Marchesini, G; Melli, A; Pisi, E; Zoli, M | 1 |
| Angiolini, A; Bianchi, FB; Dondi, C; Forlani, G; Marchesini, G; Melli, A; Pisi, E; Zoli, M | 1 |
| Hayakawa, T; Kondo, T; Nimura, Y; Noda, A; Okumura, N; Otsuka, K; Yasui, K | 1 |
| Fujisaki, K; Kamibeppu, A; Kubosono, O; Nagahama, S; Tsubouchi, H | 1 |
| Gore, MB; Orskov, H; Sherlock, S; Smith-Laing, G | 1 |
| Bustamante Murga, V; de la Villa, FM; Duque de las Heras, C; Franco Vicario, R; Sadaba Garay, F | 1 |
| Hartmann, H; Nolte, W; Ramadori, G | 1 |
| Bosch, J; Cirera, I; Escorsell, A; Fernández, M; Feu, F; García-Pagán, JC; Luca, A; Rodés, J | 1 |
| Bond, R; Evans, H; McNeil, PE; Srebernik, N | 1 |
| Groszmann, RJ; Isales, CM; Rodríguez-Pérez, F | 1 |
| Bloom, SR; Ghatei, MA; Kruszynska, YT; McIntyre, N | 1 |
| Albano, O; Antonica, G; Berardi, E; Buonamico, P; Ferraioli, G; Garcia-Tsao, G; Jensen, JE; Lerner, E; Sabbá, C; Taylor, KJ | 1 |
| Hamberg, O; Vilstrup, H | 1 |
| Lee, SS; Pak, JM | 1 |
| Albillos, A; Barrios, C; Calleja, JL; Escartín, P; García, P; Iborra, J; Lledó, JL; Rossi, I | 1 |
| Lu, MD | 1 |
| Kato, M; Moriwaki, H; Murase, M; Muto, Y | 1 |
| Dindzans, VJ; Freeman, J; O'Dorisio, T; Ruthardt, F; Salem, O; Van Thiel, DH | 1 |
| De Fronzo, RA; Petrides, AS | 1 |
| Arienti, V; Bernardi, M; Cavallari, A; Gasbarrini, G; Gozzetti, G; Mazziotti, A; Patrono, D; Piazzi, S; Scrivano, P; Trevisani, F | 1 |
| Bianchi, G; Bortoluzzi, L; Bugianesi, E; Fabbri, A; Marchesini, G; Pisi, E; Zoli, M | 1 |
| Matthews, DE; Petrides, AS; Schulze-Berge, D; Strohmeyer, G; Vogt, C | 1 |
| Ashida, H; Hashimoto, N; Kotoura, Y; Nishioka, A; Nishiwaki, M; Utsunomiya, J | 1 |
| Kerp, L; Rössle, M; Storch, MJ | 1 |
| Bianchi, G; Brizi, M; Fabbri, A; Marchesini, G; Zoli, M | 1 |
| Chen, LS; Hou, MC; Lee, FY; Lee, SD; Lin, HC | 1 |
| Hou, MC; Huang, YT; Hwang, SJ; Lee, FY; Lee, SD; Li, SM; Lin, HC; Lin, LF; Tsai, YT; Wang, SS; Yang, MC | 1 |
| Esser, U; Matthews, DE; Petrides, AS | 1 |
| Iwao, T; Miyazaki, S; Nakahara, K; Tanikawa, K; Toyonaga, A | 1 |
| Moriyama, A; Otsuki, M; Shirohara, H; Tabaru, A | 1 |
| Balanzó, J; Bulbena, O; Guarner, C; Novella, MT; Ortiz, J; Ricart, E; Rodríguez, J; Rosello, J; Sàbat, M; Soriano, G; Villanueva, C | 1 |
| Bamonti-Catena, F; Cantalamessa, L; Conte, D; Lorenzano, E; Orsatti, A; Peracchi, M; Salerno, F | 1 |
| Bugianesi, E; Burkett, E; Kalhan, S; Marchesini, G; McCullough, A | 1 |
| Chatila, R; Ferayorni, L; Groszmann, RJ; Gupta, T | 1 |
| Andreu, V; Bandi, JC; Bosch, J; Escorsell , A; García-Pagán, JC; Moitinho, E; Rodés, J | 1 |
| Iacomi, F; Laghi, V; Russo, V; Sereno, S; Toccaceli, F; Zardi, EM | 1 |
| Chang, FY; Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lee, TY; Lee, WC; Lin, HC; Yang, YY | 1 |
| Iwase, M; Ogata, H; Tashiro, K; Tsuji, H; Yoshinari, M | 1 |
| Du, R; Feng, H; Leng, X; Li, S; Zhang, Z; Zhu, J | 1 |
| Barazzoni, R; Kiwanuka, E; Tessari, P | 1 |
| Bianchi, G; Brizi, M; Fabbri, A; Loffreda, S; Manini, R; Marchesini, G; Zoli, M | 1 |
| Berthelot, P; Duvaldestin, P; Hanoune, J; Pecker, F | 1 |
| Fischer, JE; James, JH; Jeppsson, B; Ziparo, V | 1 |
| Davies, TF; Douglas, AP; Prudhoe, K | 1 |
| Blonde, L; Riddick, FA | 1 |
| Henden, T; Jynge, P; Mjos, OD; Strange, RC | 1 |
| Bílková, B; Malinovská, V; Martínek, K; Ochmanová, D; Rysánek, K | 1 |
| Francavilla, A; Jones, AF; Starzl, TE | 1 |
| Bloom, SR | 1 |
| Valverde, I | 1 |
| Ballet, F | 1 |
| Caussignac, Y; Dupre, J; McDonald, TJ; Radziuk, J; Van Vliet, S | 1 |
| Angiolini, A; Bianchi, FB; Forlani, G; Marchesini, G; Pisi, E; Scolari, MP; Zoli, M | 2 |
| Altomonte, L; Bertoli, A; Crucitti, F; Ghirlanda, G; Greco, AV; Manna, R; Rebuzzi, AG | 1 |
| Smith-Laing, G | 1 |
| Doyle, JA; Rogers, RS; Schroeter, AL | 1 |
| Alford, FP; Chisholm, DJ; Dudley, FJ; Findlay, DM | 2 |
| Chiba, T; Fukami, T; Kondo, T; Nakayama, K; Yamazoe, A | 1 |
| Golan, I; Kurochka, Iu; Levchik, A; Shpaniar, E; Zagradni, V | 1 |
| Brandi, L; Genazzani, AR; Gragnoli, G; Kristodhullu, A; Martinelli, G; Tanganelli, I | 1 |
| Andĕl, M; Brodan, V; Brodanová, M; Kuhn, E | 2 |
| Bessoff, J; Conn, HO; Felig, P; Fisher, M; Hendler, R; Sherwin, RS; Snyder, N | 1 |
| Hayakawa, H; Kawai, K; Morita, N | 1 |
| Levy, M | 1 |
| Andĕl, M; Brodan, V; Brodanová, M; Perinová, I | 1 |
| Charbonnel, B; Guillon, J | 1 |
| Luyckx, A | 1 |
| Baum, RA; Koff, RS; Pallotta, JA; Resnick, RH; Ros, E; Shurberg, JL | 1 |
| Holan, J; Kurocka, J; Levcík, A; Spanár, E; Záhradný, V | 1 |
| Czekalski, S; Eder, M; Gryczyńska, M; Kozak, W; Kozal, H; Porawska, J | 1 |
| Andĕl, M; Brodan, V; Brodanová, M; Pechar, J; Tomková, D | 1 |
| Trimble, ER | 1 |
| Valverde, I; Villanueva, ML | 1 |
| Altomonte, L; Ghirlanda, G; Greco, AV; Manna, R; Rebuzzi, A | 1 |
| Kuroda, K; Okuno, G | 1 |
| Antezana, C; Chesta, J; Defilippi, C; Generini, G | 1 |
| Arroyo, V; Clària, J; Ginès, A; Ginès, P; Jiménez, W; Piera, C; Rivera, F; Rodés, J; Salmerón, JM; Saló, J | 1 |
| Kobayashi, K; Miyakoshi, H; Miyamoto, I; Nagai, Y; Nishimura, Y; Noto, Y; Ohsawa, K | 1 |
| Alfieri, R; Anastasio, P; Bellini, L; Capasso, G; Coppola, S; De Santo, NG; del Vecchio Blanco, C; Federico, P; Loguercio, C; Spagnuolo, G | 1 |
| Barreca, T; Cataldi, A; Franceschini, R; Rolandi, E | 1 |
| Kabadi, UM | 1 |
| Blackford, S; Roberts, DL; Wright, S | 1 |
| Fujimoto, T; Fukui, H; Kubo, R; Matsumura, Y; Morita, T; Okamoto, Y; Tsujii, T; Yamada, M; Yamao, J | 1 |
| DeFronzo, RA; Groop, LC; Petrides, AS; Riely, CA | 1 |
| Kabadi, MU; Kabadi, UM; Premachandra, BN | 1 |
| Bessho, H; Kanazawa, H; Kawamura, M; Kuyama, T; Miyamoto, M; Shimoto, T; Sudo, T; Uchida, T; Yasuda, C | 1 |
| Caussignac, Y; Dupre, J; McDonald, TJ; Van Vliet, S | 1 |
| Endert, E; Romijn, JA; Sauerwein, HP | 1 |
| Cervinka, J; Jedlicka, J; Kaláb, M; Marecek, Z; Petrtýl, J | 1 |
| Bessho, H; Kawamura, M; Kuyama, T; Miyamoto, M; Sudo, T; Uchida, T; Yasuda, C | 1 |
| Bagby, BS; Kelsen, SG; Licate, L; Weber, FL | 1 |
| Abbiati, R; Bellati, G; Bianchi, GP; Dioguardi, FS; Marchesini, G; Martines, D; Roffi, L; Zoli, M | 1 |
| Burroughs, AK; Dick, R; Graffeo, M; Madden, A; McCormick, PA; McIntyre, N; Wagstaff, D | 1 |
| Bordas, JM; Gaya, J; Perez Ayuso, RM; Pique, JM; Poca, E; Saperas, E | 1 |
| Arroyo, V; Badalamenti, S; Casamitjana, R; Gaya, J; Ginés, P; Jiménez, W; Llach, J; Piera, C; Rimola, A; Rivera, F | 1 |
| Bosch, J; Casamitjana, R; Chesta, J; Navasa, M; Pilar Pizcueta, M; Rivera, F; Rodés, J; Silva, G | 1 |
| Atlan, G; Bonnet, JC; Bouissou, P; Campillo, B; Chapelain, C; Devanlay, M; Fouet, P; Frisdal, E; Wirquin, E | 1 |
| Kobayashi, M; Mitarai, Y; Nagamine, K; Yoshida, T | 1 |
| Luca, M; Noto, R; Privitera, P; Sfogliano, L | 1 |
| Antoniello, S; Auletta, M; Cacciatore, L; Cavalcanti, E; La Rocca, S; Salvatore, F | 1 |
| Ho, PW; Pun, KK; Yeung, RT | 1 |
| de Teresa, A; Golia, R; Martino, C; Pinto, M; Verrillo, A | 1 |
| Eriksson, LS; Wahren, J | 1 |
| Bernardi, M; De Palma, R; Gasbarrini, G; Grilli, F; Patrono, D; Piazzi, S; Trevisani, F | 1 |
| Altomonte, L; Caputo, S; D'Anna, LM; Ghirlanda, G; Greco, AV; Manna, R; Uccioli, L | 1 |
| Bernardi, M; Gasbarrini, G; Trevisani, F | 1 |
| Eguchi, H; Fukui, H; Hijioka, T; Kamada, T; Kawano, S; Matsumura, T; Meren, H; Sato, N; Yoshihara, H | 1 |
| Itakura, M | 1 |
| Dibildox, M; Garcia Ramos, G; Guillermo, E; Malpica, S; Nieto, L; Uribe, M; Vargas, F; Villallobos, A | 1 |
| Ide, T; Nagashima, H; Nakata, K; Shimamura, J; Taketa, K | 1 |
| Conde Yagüe, R; González Coterillo, T; González Puerta, C; Gutiérrez-Cortines Corral, MD; Ledesma Castaño, F; Valle Cagigas, M | 1 |
| Kano, T; Kawai, H; Kojima, T; Muto, Y; Takahashi, K | 1 |
| Barrao Comps, F; Ceña Lázaro, G; Ducóns García, J; Esteva Díaz, F; Juste Rullo, G; Márquez Galván, M | 1 |
| Duque, C; Franco-Vicario, R; Miguel de la Villa, F; Sádaba, F | 1 |
| Ban, N; Kawasaki, T; Kimura, T; Moriyasu, F; Nakamura, T; Ono, S; Tamada, T; Uchino, H; Yamashita, Y | 1 |
| Kawakami, K | 1 |
| Bosch, J; Casamitjana, R; Gomis, R; Mastai, R; Navasa, M; Rivera, F; Rodés, J; Silva, G | 1 |
| Fujiwara, M; Hashimoto, M; Higashi, T; Kobayashi, M; Nagashima, H; Nakatsukasa, H; Watanabe, A; Watanabe, M; Yamauchi, Y | 1 |
| Duckworth, WC; Fredi, JL; Himmelstein, S; Shankar, TP; Solomon, SS | 1 |
| Catalano, D; Mazzone, O; Noè, I; Randazzo, G | 1 |
| Ogata, T; Ohtsuka, H; Shima, S; Sugiura, Y; Tanaka, S; Yonekawa, H; Yoshizumi, Y | 1 |
| Ito, K; Miyazaki, M; Okazaki, K; Onishi, S | 1 |
| Harada, A; Hoshino, S; Kato, T; Nakao, A; Nonami, T; Suenaga, M; Takagi, H | 1 |
| Eisenstein, AB; Kabadi, UM; Konda, J | 1 |
| Hijikata, Y; Sameshima, Y; Shiozaki, Y | 1 |
| Capelli, M; Cassarani, S; Checchia, GA; Marchesini, G; Mattioli, L; Melli, A; Pisi, E; Zoli, M | 1 |
| Conde Yagüe, R; González Coterillo, T; Gutiérrez-Cortines Corral, MD; Ledesma Castaño, F; Ortiz Ortiz, M; Ramos Fernández, R | 1 |
| Beck, JC; Dupré, J; Rojas, L; Unger, RH; White, JJ | 1 |
| Deuil, R; Etienne, JP; Justin-Besançon, L; Péquignot, H; Petite, JP | 1 |
| Benabadji, A; Paraf, A; Rautureau, J | 1 |
| Kumar, D; Mehtalia, SD; Miller, LV | 1 |
| Schatz, H | 1 |
| Holík, K; Malinovská, V | 1 |
| Wang, CC; Yeung, RT | 1 |
| Brass, K | 1 |
| Barbezat, GO | 1 |
| Mosin, VI | 1 |
| Hilden, M; Juhl, E; Rehfeld, JF | 1 |
| Diaz-Fierros, M; Diego, J; Marco, J; Segovia, JM; Valverde, I; Villanueva, ML | 1 |
| Gagossi, M | 1 |
| Ceruso, D; Nicita-Mauro, V; Quartarone, M; Squadrito, G | 1 |
| Lifton, L | 1 |
| Conn, HO; Felig, P; Hendler, R; Joshi, P; Sherwin, R | 1 |
| Peterson, W; Unger, R; Walker, C | 1 |
| Marks, V; Salmols, E | 1 |
| Czyzyk, A; Kasperska, T; Lawecki, J; Rogala, H | 1 |
| Ege, P; Jacobsen, M | 1 |
| Cole, AT; Del Guercio, LR; Levine, MJ; McConn, R; Siegel, JH | 1 |
| del Guercio, LR; Levine, MJ; McConn, R; Siegel, JH | 1 |
| De Beukelaer, A; Krug, F; Verhaegen, H; Verhaegen-Declercq, ML | 1 |
| Dupré, J; White, JJ | 1 |
| Carneiro de Moura, M; Ginestal Cruz, A | 1 |
| Brunner, H; Grabner, G; Michalek, P; Paumgartner, G | 1 |
| Bianucci, G; Biddau, A; Corsi, C; Spinelli, P | 1 |
| Bianucci, G | 1 |
| Bianucci, G; Corsi, C; Spinelli, P | 1 |
| Cesano, L; Chiandussi, L; Colongo, PG; Feruglio, FS; Greco, F; Sardi, G | 1 |
12 review(s) available for glucagon and Liver Cirrhosis
| Article | Year |
|---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
[Colchicine: rationale for its use in liver disease].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Glucagon; Humans; Interleukin-1; Liver Cirrhosis; Liver Cirrhosis, Biliary; Molecular Structure; Phytotherapy; Tubulin Modulators | 1990 |
[Current aspects of the etiopathogenesis of diabetes mellitus].
Topics: Carbohydrates; Cushing Syndrome; Diabetes Mellitus; Diabetes Mellitus, Type 1; Endocrine System Diseases; Glucagon; HLA Antigens; Humans; Insulin; Islets of Langerhans; Liver Cirrhosis; Paraneoplastic Endocrine Syndromes; Somatostatin; Virus Diseases | 1981 |
Disturbances of metabolic homeostasis is liver disease.
Topics: Fasting; Glucagon; Gluconeogenesis; Glucose Tolerance Test; Growth Hormone; Homeostasis; Humans; Hydrocortisone; Insulin; Lactates; Lactic Acid; Lipids; Liver Cirrhosis; Liver Diseases; Pyruvates; Pyruvic Acid | 1981 |
[Endocrine changes in hepatic cirrhosis].
Topics: Adrenal Cortex Hormones; Carbohydrate Metabolism; Endocrine Glands; Gastrins; Glucagon; Glucose Tolerance Test; Gonadal Steroid Hormones; Growth Hormone; Hormones; Humans; Insulin; Insulin Resistance; Liver Cirrhosis; Prolactin; Thyroid Hormones | 1981 |
Glucose metabolism and liver cirrhosis.
Topics: Catecholamines; Chronic Disease; Diabetes Mellitus, Type 2; Fatty Acids; Glucagon; Glucose; Humans; Hyperglycemia; Hyperinsulinism; Insulin Resistance; Insulin-Like Growth Factor I; Liver Cirrhosis; Nutrition Disorders | 1995 |
Glucagon in portal hypertension.
Topics: Animals; Glucagon; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Cirrhosis, Experimental; Splanchnic Circulation; Vasomotor System | 1994 |
[Diabetes mellitus secondary to liver diseases. A review (author's transl)].
Topics: Diabetes Mellitus; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Humans; Hypertension, Portal; Hypokalemia; Insulin; Insulin Resistance; Liver Cirrhosis; Pancreatic Diseases | 1975 |
[The role of glucagon in hyperglycemia. A review (author's transl)].
Topics: Acromegaly; Adult; Burns; Child; Cushing Syndrome; Diabetes Mellitus; Glucagon; Gluconeogenesis; Glucose; Humans; Hyperglycemia; Infections; Insulin; Islets of Langerhans; Liver; Liver Cirrhosis; Myocardial Infarction; Pancreatic Diseases; Pheochromocytoma; Prediabetic State; Shock; Somatostatin | 1975 |
Glucagon and the pancreas, liver and bile ducts.
Topics: Animals; Bile Ducts; Carbohydrate Metabolism; Cholecystokinin; Gallbladder; Glucagon; Humans; Insulin; Liver; Liver Cirrhosis; Pancreas; Pancreatic Juice; Pancreatitis | 1974 |
[Carbohydrate metabolism in liver diseases].
Topics: Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Hepatitis; Humans; Hyperglycemia; Hypoglycemia; Insulin; Insulin Resistance; Insulin Secretion; Liver; Liver Cirrhosis; Liver Diseases; Pancreatitis; Tolbutamide | 1974 |
[Glucagon mediated insulin release in man].
Topics: Blood Glucose; Diabetes Mellitus; Ethanol; Fasting; Fatty Acids, Nonesterified; Glucagon; Glucose; Humans; Hyperglycemia; Injections, Intravenous; Insulin; Insulin Secretion; Liver Cirrhosis; Methandrostenolone; Obesity; Pancreas | 1968 |
18 trial(s) available for glucagon and Liver Cirrhosis
| Article | Year |
|---|---|
Effect of aerobic exercise training on the fat fraction of the liver in persons with chronic hepatitis B and hepatic steatosis: Trial protocol for a randomized controlled intervention trial- The FitLiver study.
Topics: Exercise; Glucagon; Glucose; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Randomized Controlled Trials as Topic | 2023 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Overnight glucose infusion suppresses renal ammoniagenesis and reduces hyperammonaemia induced by a simulated bleed in cirrhotic patients.
Topics: Aged; Amino Acids; Ammonia; Cross-Over Studies; Fasting; Female; Gastrointestinal Hemorrhage; Glucagon; Gluconeogenesis; Glucose; Humans; Hyperammonemia; Infusions, Intravenous; Insulin; Kidney; Liver Cirrhosis; Male; Middle Aged; Severity of Illness Index; Time Factors | 2012 |
[Therapeutic effect of somatostatin analog octreotide on esophaged-gastric varices bleeding].
Topics: Esophageal and Gastric Varices; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Glucagon; Humans; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide; Octreotide; Somatostatin | 2003 |
Mechanism of dichloroacetate-induced hypolactatemia in humans with or without cirrhosis.
Topics: Adult; Alanine; C-Peptide; Dichloroacetic Acid; Female; Gas Chromatography-Mass Spectrometry; Glucagon; Humans; Insulin; Kinetics; Lactates; Liver; Liver Cirrhosis; Male; Oxidation-Reduction; Pyruvic Acid | 2004 |
Effect of somatostatin versus octreotide on portal haemodynamics in patients with cirrhosis and portal hypertension.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Female; Glucagon; Humans; Hypertension, Portal; Insulin-Like Growth Factor I; Liver Cirrhosis; Male; Middle Aged; Octreotide; Portal Pressure; Somatostatin | 2005 |
Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
Topics: Dose-Response Relationship, Drug; Double-Blind Method; Female; Glucagon; Hemodynamics; Humans; Injections, Intravenous; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Placebos; Somatostatin | 1995 |
Octreotide blunts postprandial splanchnic hyperemia in cirrhotic patients: a double-blind randomized echo-Doppler study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Eating; Fasting; Female; Glucagon; Humans; Hyperemia; Liver Cirrhosis; Male; Middle Aged; Octreotide; Placebos; Rheology; Splanchnic Circulation; Ultrasonography | 1995 |
Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertension.
Topics: Blood Glucose; Blood Pressure; Cardiac Output; Eating; Female; Glucagon; Heart Rate; Hemodynamics; Hepatic Veins; Humans; Hyperemia; Hypertension, Portal; Insulin; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Octreotide; Placebos; Splanchnic Circulation; Stroke Volume; Time Factors; Vascular Resistance | 1994 |
Early and late changes in fasting and absorptive plasma amino acids and ammonia after distal splenorenal shunt in cirrhosis.
Topics: Adult; Aged; Amino Acids; Ammonia; Esophageal and Gastric Varices; Female; Follow-Up Studies; Glucagon; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Sclerotherapy; Splenorenal Shunt, Surgical | 1994 |
Local arterial vasoconstriction induced by octreotide in patients with cirrhosis.
Topics: Arm; Female; Glucagon; Humans; Infusions, Intra-Arterial; Liver Cirrhosis; Male; Methacholine Chloride; Octreotide; Regional Blood Flow; Vasoconstriction; Vasoconstrictor Agents | 2000 |
Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension.
Topics: Adult; Aged; Blood Pressure; Drug Tolerance; Female; Gastrointestinal Agents; Glucagon; Heart Rate; Humans; Hypertension, Portal; Injections, Intravenous; Liver Cirrhosis; Male; Middle Aged; Octreotide; Placebos; Splanchnic Circulation | 2001 |
Effects of long-term oral misoprostol administration on hepatic amino acid-nitrogen metabolism in patients with cirrhosis.
Topics: Administration, Oral; Adult; Aged; Amino Acids; Anti-Ulcer Agents; Blood Urea Nitrogen; Glucagon; Humans; Insulin; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Misoprostol; Nitrogen; Urea | 2002 |
Plasma cyclic adenosine-3', 5'-monophosphate response to glucagon in patients with liver disease.
Topics: Blood Glucose; Cholestasis; Clinical Trials as Topic; Cyclic AMP; Glucagon; Humans; Liver Cirrhosis; Liver Diseases | 1976 |
Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group.
Topics: Adult; Aged; Amino Acids, Branched-Chain; Blood Glucose; Caseins; Chronic Disease; Double-Blind Method; Female; Glucagon; Hepatic Encephalopathy; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Multicenter Studies as Topic; Nitrogen; Placebos; Randomized Controlled Trials as Topic; Thyroid Hormones | 1990 |
Role of gluconeogenesis from amino acids in determining fasting and absorptive levels of plasma ammonia in cirrhosis.
Topics: Adult; Aged; Amino Acids; Ammonia; Dietary Proteins; Fasting; Female; Glucagon; Gluconeogenesis; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Somatostatin | 1988 |
Beneficial effect of vegetable protein diet supplemented with psyllium plantago in patients with hepatic encephalopathy and diabetes mellitus.
Topics: Adult; Amino Acids; Bilirubin; Diabetes Mellitus; Dietary Fiber; Dietary Proteins; Energy Intake; Female; Food, Fortified; Glucagon; Hepatic Encephalopathy; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Neomycin; Plant Proteins; Psyllium; Tolbutamide | 1985 |
Blood ammonia levels in advanced cirrhosis during therapeutic elevation of the insulin:glucagon ratio.
Topics: Administration, Oral; Ammonia; Diet Therapy; Dietary Proteins; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Liver; Liver Cirrhosis; Radioimmunoassay; Urea | 1974 |
199 other study(ies) available for glucagon and Liver Cirrhosis
| Article | Year |
|---|---|
Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis.
Topics: Animals; Cholesterol; Collagen; Disease Models, Animal; Galectin 3; Glucagon; Glucagon-Like Peptide 1; Inflammation; Interleukin-2; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Receptors, Antigen, T-Cell; Receptors, Glucagon; Recombinant Fusion Proteins; Transaminases; Triglycerides | 2022 |
Liver Transplantation in a Woman with Mahvash Disease.
Topics: Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Genetic Diseases, Inborn; Glucagon; Glucagon-Secreting Cells; Humans; Hypertension, Portal; Hypertrophy; Liver Cirrhosis; Liver Transplantation; Pancreatic Diseases | 2023 |
Glucagon is associated with NAFLD inflammatory progression in type 2 diabetes, not with NAFLD fibrotic progression.
Topics: Adult; China; Diabetes Mellitus, Type 2; Glucagon; Humans; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease | 2021 |
Impaired Follistatin Secretion in Cirrhosis.
Topics: Biomarkers; Case-Control Studies; Female; Follistatin; Follow-Up Studies; Gastrointestinal Agents; Glucagon; Hormones; Humans; Infusions, Intravenous; Liver Cirrhosis; Male; Middle Aged; Prognosis; Somatostatin | 2016 |
Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastric Mucosa; Gastroscopy; Glucagon; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Severity of Illness Index; Splanchnic Circulation; Stomach Diseases; Vascular Resistance; Vasodilation; Venous Pressure | 2009 |
Insulin sensitivity and body composition in cirrhosis: changes after TIPS.
Topics: Body Composition; C-Peptide; Diabetes Mellitus; Energy Metabolism; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin Resistance; Liver; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Predictive Value of Tests; Rest | 2010 |
Effect of transjugular intrahepatic portosystemic shunt on glycometabolism in cirrhosis patients.
Topics: Adult; Aged; Algorithms; Cardiac Output; Case-Control Studies; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Hormones; Humans; Hyperinsulinism; Hypertension, Portal; Insulin Resistance; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Postoperative Care; Prediabetic State; Predictive Value of Tests; Preoperative Care; Sensitivity and Specificity; Treatment Outcome | 2012 |
Serum bile acids and leptin interact with glucose metabolism in patients with liver cirrhosis.
Topics: Adipose Tissue, White; Adult; Bile Acids and Salts; Female; Glucagon; Glucose; Humans; Hyperglycemia; Insulin Resistance; Intestinal Mucosa; Leptin; Liver; Liver Cirrhosis; Male; Middle Aged; Parenteral Nutrition; Postprandial Period | 2013 |
Decreased expression of insulin and increased expression of pancreatic transcription factor PDX-1 in islets in patients with liver cirrhosis: a comparative investigation using human autopsy specimens.
Topics: Aged; Biopsy; Diabetes Mellitus, Type 2; Female; Glucagon; Homeodomain Proteins; Humans; Hypertrophy; Insulin; Islets of Langerhans; Ki-67 Antigen; Liver Cirrhosis; Male; Middle Aged; Proliferating Cell Nuclear Antigen; Retrospective Studies; Somatostatin; Trans-Activators | 2013 |
[The role of the serum BG(P-B) value from glucagon loading test in assessing liver function of cirrhosis patients].
Topics: Adult; Aged; Female; Glucagon; Glucose Tolerance Test; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged | 2003 |
Significance of blood sugar and serum electrolyte changes in cirrhosis following glucose, insulin, glucagon, or epinephrine.
Topics: Blood Glucose; Electrolytes; Epinephrine; Glucagon; Glucose; Humans; Insulin; Liver Cirrhosis | 1956 |
Glucagon infusion test in bilharzial hepatic fibrosis.
Topics: Animals; Carbohydrate Metabolism; Glucagon; Humans; Liver Cirrhosis; Liver Diseases, Parasitic; Liver Function Tests; Schistosoma; Schistosomiasis | 1962 |
[EFFECT OF GLUCAGON INFUSION ON SYSTEMIC AND HEPATOSPLANCHNIC HEMODYNAMICS IN NORMAL AND CIRRHOTIC SUBJECTS].
Topics: Blood Circulation; Glucagon; Hemodynamics; Humans; Infusions, Parenteral; Liver Circulation; Liver Cirrhosis; Pharmacology | 1964 |
LIPOATROPHIC DIABETES. I. STUDIES CONCERNING ENDOCRINE FUNCTION AND CARBOHYDRATE METABOLISM.
Topics: Adolescent; Carbohydrate Metabolism; Diabetes Mellitus, Lipoatrophic; Diabetes Mellitus, Type 1; Drug Tolerance; Epinephrine; Fatty Acids; Glucagon; Glucose Tolerance Test; Hepatomegaly; Humans; Infant; Insulin; Insulin Resistance; L-Lactate Dehydrogenase; Leucine; Lipids; Lipodystrophy; Liver; Liver Cirrhosis; Liver Function Tests; Metyrapone; Pharmacology; Pituitary-Adrenal Function Tests; Radiography; Tolbutamide; Transaminases; Urine | 1965 |
HEPATIC DNA SYNTHESIS AND REGENERATION.
Topics: Adrenal Cortex Hormones; Anabolic Agents; Autoradiography; Biopsy; Diet; Diet Therapy; DNA; Drug Therapy; Folic Acid; Glucagon; Hepatitis; Hepatitis A; Liver Cirrhosis; Liver Regeneration; Metabolism; Minerals; Oxygen Inhalation Therapy; RNA; Steroids; Thymidine; Toxicology; Tritium; Vitamin B 12 | 1964 |
[EFFECT OF GLUCAGON INFUSION ON PERIPHERAL AND HEPATOSPLANCHNIC METABOLISM OF LIPIDS IN NORMAL SUBJECTS AND CIRRHOTIC PATIENTS].
Topics: Glucagon; Humans; Lipid Metabolism; Lipids; Liver Cirrhosis | 1965 |
[EFFECT OF GLUCAGON INFUSION ON PERIPHERAL AND HEPATOSPLANCHNIC METABOLISM OF GLYCIDES IN NORMAL SUBJECTS AND IN CIRRHOTIC PATIENTS].
Topics: Glucagon; Glucose; Humans; Liver Cirrhosis | 1965 |
Inhibition of glucagon improves splanchnic hyporesponse to terlipressin in cirrhotic rats with blood retention in the gastric lumen.
Topics: Animals; Antibodies; Blood; Drug Synergism; Gastric Lavage; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Glucagon; Hypertension, Portal; Liver Cirrhosis; Lypressin; Male; Octreotide; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Stomach; Terlipressin; Vasoconstrictor Agents | 2005 |
Fasting hyperglucagonemia in patients with transjugular intrahepatic portosystemic shunts (TIPS).
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Complications; Female; Glucagon; Glycated Hemoglobin; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic | 2005 |
[Hypoglycemia and primary cancer of the liver. Hormonal titers. Action of diazoxide].
Topics: Adult; Diazoxide; Glucagon; Growth Hormone; Humans; Hypoglycemia; Insulin; Liver Cirrhosis; Liver Neoplasms; Male; Polycythemia | 1967 |
Somatostatin infusion in liver cirrhosis: glucagon control of glucose homeostasis.
Topics: Adult; Blood Glucose; Glucagon; Homeostasis; Humans; Infusions, Parenteral; Liver Cirrhosis; Male; Middle Aged; Reference Values; Somatostatin | 1980 |
Evidence for an augmented glucagon dependence of hepatic glucose production in cirrhosis of the liver.
Topics: Aged; Blood Glucose; Glucagon; Glucose; Humans; Insulin; Liver; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Somatostatin | 1982 |
Colchicine improves the alterations in the liver adenylate cyclase system of cirrhotic rats.
Topics: Adenylyl Cyclases; alpha-Fetoproteins; Animals; Colchicine; Glucagon; Insulin; Kinetics; Liver; Liver Cirrhosis; Male; Rats; Rats, Inbred Strains; Receptor, Insulin; Receptors, Cell Surface; Receptors, Glucagon | 1981 |
[L and M isoenzymes of hepatic pyruvate kinase and their hormone dependence].
Topics: Animals; Glucagon; Humans; Insulin; Isoenzymes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Regeneration; Male; Pyruvate Kinase; Rats; Rats, Inbred Strains; Rats, Zucker | 1982 |
Anomalous plasma cyclic AMP responses to glucagon in patients with liver disease.
Topics: Adult; Cyclic AMP; Dose-Response Relationship, Drug; Female; Glucagon; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged | 1980 |
Hepatic gluconeogenic key enzymes in patients with hepatic cancer.
Topics: Adult; Aged; Animals; Blood Glucose; C-Peptide; Carcinoma, Hepatocellular; Female; Glucagon; Gluconeogenesis; Glucose-6-Phosphatase; Humans; Insulin; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Phosphoenolpyruvate Carboxykinase (GTP); Rats | 1980 |
[Effect of glucagon on blood gastrin levels in hepatic cirrhosis: correlation with blood levels of cyclic AMP].
Topics: Cyclic AMP; Gastrins; Glucagon; Humans; Liver Cirrhosis | 1980 |
Down-regulation of insulin receptors in postnecrotic cirrhosis of liver.
Topics: Adult; Aged; Blood Glucose; Cyclic AMP; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Monocytes; Portasystemic Shunt, Surgical; Receptor, Insulin | 1982 |
[The glucagon-dependent stimulation of cyclic AMP--a new diagnostic liver test?].
Topics: Adenylyl Cyclases; Cyclic AMP; Glucagon; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Stimulation, Chemical | 1983 |
Plasma amino acid response to protein ingestion in patients with liver cirrhosis.
Topics: Amino Acids; Amino Acids, Branched-Chain; Ammonia; Blood Glucose; Dietary Proteins; Glucagon; Glucose Tolerance Test; Humans; Insulin; Liver Cirrhosis | 1983 |
The presence of glucagon in ascitic fluid in cirrhotic patients.
Topics: Adult; Ascitic Fluid; Biological Transport; Blood Glucose; Glucagon; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Peritoneum | 1983 |
Hyperglucagonemia in hepatic cirrhosis: its relation to hepatocellular dysfunction and normalization on recovery.
Topics: Adult; Bilirubin; Blood Glucose; Evaluation Studies as Topic; Glucagon; Humans; Insulin; Islets of Langerhans; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Portasystemic Shunt, Surgical; Prothrombin Time | 1984 |
Effects of branched chain amino acid infusion on glucose metabolism in cirrhotic patients with encephalopathy.
Topics: Amino Acids; Amino Acids, Branched-Chain; Blood Glucose; Female; Glucagon; Glucose; Hepatic Encephalopathy; Humans; Infusions, Parenteral; Insulin; Liver Cirrhosis; Male; Time Factors | 1983 |
Effect of simultaneous administration of glucagon and insulin on renal function in patients with liver cirrhosis and ascites.
Topics: Glucagon; Humans; Infusions, Parenteral; Insulin; Kidney; Liver Cirrhosis; Male; Middle Aged; Natriuresis; Prothrombin Time; Water-Electrolyte Balance | 1984 |
Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow.
Topics: Adult; Carbohydrate Metabolism; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Humans; Insulin; Ketone Bodies; Leg; Liver; Liver Circulation; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Portasystemic Shunt, Surgical; Triglycerides | 1984 |
Characteristic features of plasma amino acid, plasma pancreatic glucagon, serum insulin concentrations in cirrhotic patients with histories of chronic alcohol consumption.
Topics: Adult; Alcoholism; Amino Acids; Amino Acids, Branched-Chain; Female; Glucagon; Hepatic Encephalopathy; Humans; Insulin; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Function Tests; Male; Middle Aged | 1984 |
[Preoperative glucagon-insulin therapy on the patient with hepatic failure secondary to combined valvular disease].
Topics: Glucagon; Humans; Infusions, Parenteral; Insulin; Liver Cirrhosis; Male; Middle Aged; Mitral Valve Insufficiency; Mitral Valve Stenosis; Preoperative Care; Tricuspid Valve Insufficiency | 1984 |
Plasma amino acid imbalance in alcoholic liver cirrhosis.
Topics: Adult; Aged; Amino Acids; Amino Acids, Branched-Chain; Glucagon; Humans; Insulin; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Phenylalanine; Tyrosine | 1984 |
Comparative study of amino acid, ammonia and pancreatic hormone levels in the blood of cirrhotic patients following intragastric and intravenous administration of a branched-chain amino acid-enriched solution.
Topics: Amino Acids; Amino Acids, Branched-Chain; Ammonia; Enteral Nutrition; Glucagon; Humans; Infusions, Parenteral; Insulin; Liver Cirrhosis; Pancreatic Hormones | 1983 |
Effect of TRH on plasma glucagon in cirrhotic patients.
Topics: Arginine; Esophageal and Gastric Varices; Glucagon; Humans; Liver Cirrhosis; Saline Solution, Hypertonic; Thyrotropin-Releasing Hormone | 1983 |
Impaired plasma amino-acid clearance in patients with cirrhosis of the liver and portocaval shunt--its relation to insulin resistance.
Topics: 3-Hydroxybutyric Acid; Adult; Amino Acids; Blood Glucose; C-Peptide; Catecholamines; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hydroxybutyrates; Insulin; Insulin Resistance; Liver Cirrhosis; Male; Middle Aged; Portacaval Shunt, Surgical; Reference Values | 1984 |
[Big plasma glucagon in patients with liver cirrhosis. The discrepancy in values of immunoreactive glucagon measured by use of two different antisera against pancreatic glucagon, 30K and OAL-123].
Topics: Chromatography, Gel; Glucagon; Glucagon-Like Peptides; Humans; Immune Sera; Liver Cirrhosis; Peptides; Radioimmunoassay | 1984 |
[Nature of "big plasma glucagon" in plasma of human and rats].
Topics: Animals; Chromatography; Glucagon; Glucagon-Like Peptides; Humans; Liver Cirrhosis; Male; Molecular Weight; Peptides; Protease Inhibitors; Radioimmunoassay; Rats; Rats, Inbred Strains | 1984 |
[The blood sugar raising effect of glucagon in liver cirrhosis].
Topics: Blood Glucose; Glucagon; Humans; Insulin; Liver Cirrhosis | 1982 |
Effects of insulin and glucagon on serum amino acid concentrations in liver disease.
Topics: Amino Acids; Amino Acids, Branched-Chain; Drug Therapy, Combination; Glucagon; Hepatitis; Humans; Infusions, Parenteral; Insulin; Liver Cirrhosis | 1982 |
Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
Topics: Adult; Aged; Arginine; C-Peptide; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Liver Cirrhosis; Male; Middle Aged; Nephritis; Pancreatic Neoplasms; Peptides; Tolbutamide | 1982 |
[Changes in carbohydrate metabolism in hepatic cirrhosis].
Topics: Carbohydrate Metabolism; Diabetes Mellitus; Glucagon; Glucose Tolerance Test; Humans; Insulin Resistance; Liver Cirrhosis; Male; Middle Aged | 1983 |
Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.
Topics: Adult; Aged; Bilirubin; Blood Glucose; Blood Pressure; Eating; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Liver; Liver Cirrhosis; Male; Middle Aged; Pancreas; Serum Albumin | 1980 |
The mechanism of the carbohydrate intolerance of cirrhosis.
Topics: Adult; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Serum Albumin | 1980 |
[Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
Topics: Adult; Aged; Ascites; C-Peptide; Female; Glucagon; Humans; Hyperglycemia; Hyperinsulinism; Insulin; Liver Cirrhosis; Male; Middle Aged; Peptides | 1980 |
[Treatment of hepatic encephalopathy with glucagon-insulin (author's transl)].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Glucagon; Hepatic Encephalopathy; Hepatitis; Humans; Infusions, Parenteral; Insulin; Liver Cirrhosis; Male; Middle Aged | 1980 |
[Changes in plasma glucagon, insulin, C-peptide and amino acids during the intravenous induced hyperammonemia test in the cirrhotic].
Topics: Amino Acids; Ammonia; Ammonium Chloride; C-Peptide; Female; Glucagon; Humans; Infusions, Parenteral; Insulin; Liver Cirrhosis; Male; Middle Aged | 1981 |
Hormonal and metabolic changes in hepatic cirrhosis.
Topics: Adult; Aged; Blood Glucose; Fasting; Female; Glucagon; Glucose; Glucose Tolerance Test; Glycerol; Hormones; Humans; Hydrocortisone; Insulin; Lactates; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Pyruvates | 1982 |
[Carbohydrate tolerance in the cirrhotic patient].
Topics: Dietary Carbohydrates; Glucagon; Glucose; Humans; Hyperglycemia; Insulin; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Glycogen | 1981 |
Ammonia-induced changes in pancreatic hormones and plasma amino acids in patients with liver cirrhosis.
Topics: Adult; Aged; Amino Acids; Ammonia; Ammonium Chloride; Blood Glucose; Female; Glucagon; Hepatic Encephalopathy; Hepatitis; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Pancreatic Hormones | 1982 |
[Blood glucose and glucoregulatory hormones in liver cirrhosis: a study of 24 hour profiles and of the role of portal-systemic shunting].
Topics: Adult; Aged; Blood Glucose; Female; Glucagon; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Surgical | 1982 |
[Hyperglucagonemia in patients with liver cirrhosis (author's transl)].
Topics: Glucagon; Humans; Liver Cirrhosis; Radioimmunoassay | 1982 |
Plasma pancreatic glucagon in pancreatic and primary diabetes, and liver cirrhosis: application of a correction to the radioimmunoassay for pancreatic glucagon.
Topics: Aged; Chronic Disease; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Humans; Liver Cirrhosis; Male; Middle Aged; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatitis; Radioimmunoassay | 1982 |
[Hyperglucagonemia in liver cirrhosis: relationship to hepatic dysfunction and portal systemic shunt (author's transl)].
Topics: Glucagon; Humans; Liver; Liver Cirrhosis; Portasystemic Shunt, Surgical | 1981 |
Hyperglucagonaemia in cirrhosis. Relationship to hepatocellular damage.
Topics: Adolescent; Adult; Aged; Fasting; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Kinetics; Liver Cirrhosis; Male; Middle Aged; Reference Values | 1980 |
[Glucagon test in hepatic cirrhosis. Its diagnostic and prognostic value].
Topics: Female; Glucagon; Humans; Injections, Intravenous; Liver Cirrhosis; Male; Middle Aged; Prognosis | 1980 |
Metabolic epidermal necrosis in two dogs with different underlying diseases.
Topics: Alanine Transaminase; Alkaline Phosphatase; Amino Acids; Animals; Blood Glucose; Carcinoma; Dermatitis; Dog Diseases; Dogs; Female; Foot Dermatoses; Glucagon; Immunoenzyme Techniques; Keratosis; Liver Cirrhosis; Male; Necrosis; Pancreatic Neoplasms; Skin | 1995 |
Platelet cytosolic calcium, peripheral hemodynamics, and vasodilatory peptides in liver cirrhosis.
Topics: Adult; Aged; Blood Platelets; Blood Pressure; Calcium; Cytosol; Glucagon; Hemodynamics; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Muscle, Smooth, Vascular; Substance P; Vascular Resistance; Vasoactive Intestinal Peptide; Vasodilation | 1993 |
Insulin secretion and plasma levels of glucose-dependent insulinotropic peptide and glucagon-like peptide 1 [7-36 amide] after oral glucose in cirrhosis.
Topics: Adult; Blood Glucose; C-Peptide; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Humans; Insulin; Insulin Secretion; Liver Cirrhosis; Male; Middle Aged; Peptide Fragments | 1995 |
Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Amino Acids; Blood Glucose; Female; Glucagon; Glucose; Humans; Hyperglycemia; Liver; Liver Cirrhosis; Male; Middle Aged; Nitrogen; Somatostatin; Urea | 1994 |
[Oral glucose tolerance test and glucagon loading test as useful parameters for evaluating liver functional reserve].
Topics: Adult; Carcinoma, Hepatocellular; Cyclic AMP; Female; Glucagon; Glucose Tolerance Test; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Prognosis | 1993 |
[Recent advances in the treatment of decompensated liver cirrhosis].
Topics: Albumins; Alprostadil; Amino Acids, Branched-Chain; Diuretics; Glucagon; Hepatic Encephalopathy; Humans; Insulin; Jaundice; Lactulose; Liver Cirrhosis | 1994 |
Liver transplantation following preoperative closure of intrapulmonary shunts.
Topics: Adult; Glucagon; Humans; Hypoxia; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Octreotide | 1994 |
Failure of glucagon to stimulate hepatic glycogenolysis in well-nourished patients with mild cirrhosis.
Topics: Adult; Amino Acids; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Glycogen; Humans; Insulin; Liver; Liver Cirrhosis; Male; Middle Aged; Molecular Weight; Time Factors | 1994 |
Unresponsiveness of hepatic nitrogen metabolism to glucagon infusion in patients with cirrhosis: dependence on liver cell failure.
Topics: Adult; Alanine; Amino Acids; Glucagon; Humans; Kinetics; Liver; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Nitrogen; Urea | 1993 |
Glucose resistance contributes to diabetes mellitus in cirrhosis.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Complications; Diabetes Mellitus; Drug Resistance; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Humans; Insulin; Lactates; Lactic Acid; Liver; Liver Cirrhosis; Male; Middle Aged; Osmolar Concentration; Oxidation-Reduction | 1993 |
Analysis of hepatic encephalopathy after distal splenorenal shunt--PTP image and pancreatic hormone kinetics.
Topics: Blood Glucose; Collateral Circulation; Esophageal and Gastric Varices; Follow-Up Studies; Glucagon; Hepatic Encephalopathy; Humans; Insulin; Liver Cirrhosis; Pancreatic Hormones; Portal Vein; Portography; Regional Blood Flow; Splenorenal Shunt, Surgical | 1993 |
[Pulsatile insulin secretion into the portal vein in liver cirrhosis].
Topics: Aged; Blood Glucose; C-Peptide; Catheterization, Peripheral; Female; Glucagon; Glucose; Hepatitis; Humans; Insulin; Insulin Secretion; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Portal Vein; Pulsatile Flow; Radiography, Interventional; Time Factors | 1993 |
Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.
Topics: Administration, Oral; Adult; Aged; Alanine; Ammonia; Female; Glucagon; Hepatic Encephalopathy; Humans; Lipid Peroxides; Liver; Liver Cirrhosis; Male; Middle Aged; Nitrogen; Prospective Studies; Sulfates; Urea; Zinc; Zinc Compounds; Zinc Sulfate | 1996 |
Portal hypertensive colopathy in patients with cirrhosis.
Topics: Aged; Case-Control Studies; Colon; Colonoscopy; Glucagon; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Portal Pressure; Rectum; Varicose Veins | 1996 |
Hyperglucagonaemia in cirrhotic patients and its relationship to the severity of cirrhosis and haemodynamic values.
Topics: Adult; Aged; Bilirubin; Esophageal and Gastric Varices; Female; Glucagon; Hemodynamics; Humans; Liver Cirrhosis; Male; Middle Aged; Prothrombin Time; Severity of Illness Index | 1996 |
Effect of moderate exercise on insulin sensitivity and substrate metabolism during post-exercise recovery in cirrhosis.
Topics: Adult; Exercise; Female; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Lactic Acid; Liver Cirrhosis; Male; Middle Aged | 1997 |
Effects of glucagon on superior mesenteric artery and femoral artery haemodynamics in humans.
Topics: Aged; Female; Femoral Artery; Glucagon; Hemodynamics; Humans; Laser-Doppler Flowmetry; Liver Cirrhosis; Male; Mesenteric Artery, Superior; Middle Aged | 1997 |
Effects of branched-chain-enriched amino acid solution on insulin and glucagon secretion and blood glucose level in liver cirrhosis.
Topics: Adult; Aged; Amino Acids, Branched-Chain; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glucagon; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Liver Cirrhosis; Male; Middle Aged; Treatment Outcome | 1998 |
Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites.
Topics: Aldosterone; Ascites; Blood Pressure; Epoprostenol; Female; Glucagon; Heart Rate; Hemodynamics; Humans; Injections, Subcutaneous; Kidney; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide; Octreotide; Renin; Splanchnic Circulation; Vasoconstrictor Agents; Vasomotor System | 1998 |
Pattern of plasma cyclic nucleotides and related hormones in liver cirrhosis and hepatocellular carcinoma.
Topics: Adult; Aged; Atrial Natriuretic Factor; Carcinoma, Hepatocellular; Cyclic AMP; Cyclic GMP; Female; Glucagon; Hemochromatosis; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged | 1998 |
Quantification of gluconeogenesis in cirrhosis: response to glucagon.
Topics: Adult; Female; Glucagon; Gluconeogenesis; Glucose; Humans; Liver Cirrhosis; Male; Middle Aged; Urea | 1998 |
Doppler sonography measurement of portal blood flow velocity after glucagon injection in patients with chronic HCV infection.
Topics: Adult; Aged; Blood Flow Velocity; Female; Gastrointestinal Agents; Glucagon; Hepatitis C, Chronic; Humans; Injections; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Portal System; Ultrasonography, Doppler | 2001 |
Adaptive vasodilatory response after octreotide treatment.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Blotting, Western; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucagon; Hypertension, Portal; Indomethacin; Liver Cirrhosis; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrites; Octreotide; Rats; Rats, Sprague-Dawley; Somatostatin; Splanchnic Circulation; Vasoconstrictor Agents; Vasodilation | 2001 |
Portal blood flow and glucose tolerance or peripheral insulin and glucagon concentrations in patients with liver cirrhosis.
Topics: Female; Glucagon; Glucose Tolerance Test; Hepatitis B; Hepatitis C; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Regional Blood Flow | 2002 |
[Plasma level of glucagon in cirrhotic patients with portal hypertension during operation of portacaval shunts].
Topics: Adult; Aged; Female; Glucagon; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Portacaval Shunt, Surgical | 1999 |
Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
Topics: Adult; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Dietary Carbohydrates; Fatty Acids, Nonesterified; Female; Food; Glucagon; Humans; Hyperglycemia; Insulin; Insulin Resistance; Kinetics; Lactic Acid; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Splanchnic Circulation | 2001 |
The adenylate cyclase system in human liver: characterization, subcellular distribution and hormonal sensitivity in normal or cirrhotic adult, and in foetal liver.
Topics: Adenosine; Adenylyl Cyclases; Adult; Aged; Catecholamines; Cell Membrane; Dose-Response Relationship, Drug; Enzyme Activation; Female; gamma-Glutamyltransferase; Glucagon; Guanine Nucleotides; Humans; Leucyl Aminopeptidase; Liver; Liver Cirrhosis; Male; Middle Aged; Nucleotidases; Sodium Fluoride; Subcellular Fractions | 1979 |
Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Biological Transport; Blood-Brain Barrier; Brain; Dogs; Glucagon; Glutamine; Haplorhini; Hepatic Encephalopathy; Humans; Insulin; Liver Cirrhosis; Phenylalanine; Portacaval Shunt, Surgical; Rats; Tryptophan; Tyrosine | 1979 |
Hypoglycemia: the "undisease".
Topics: Adenoma, Islet Cell; Adrenal Cortex Diseases; Adult; Aged; Blood Glucose; Child; Child, Preschool; Diagnosis, Differential; Fasting; Glucagon; Glucose Tolerance Test; Growth Hormone; Hormones, Ectopic; Humans; Hypoglycemia; Hypoglycemic Agents; Infant; Infant, Newborn; Liver Cirrhosis; Metabolism, Inborn Errors; Pancreatic Neoplasms | 1976 |
The effect of glucagon on plasma cyclic AMP and glucose concentrations in patients with alcoholic cirrhosis.
Topics: Adult; Alcoholism; Blood Glucose; Cyclic AMP; Glucagon; Humans; Liver Cirrhosis; Male; Middle Aged | 1977 |
[Effect of glucagon on plasma levels of 3',5'-adenosine monophosphate in patients with liver cirrhosis (author's transl)].
Topics: Cyclic AMP; Glucagon; Humans; Liver Cirrhosis | 1977 |
Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis.
Topics: Adenylyl Cyclases; Adolescent; Adult; Blood Glucose; Child; Child, Preschool; Cyclic AMP; Glucagon; Humans; Infant; Insulin; Liver; Liver Cirrhosis; Middle Aged | 1978 |
Signals for glucagon secretion.
Topics: Adrenalectomy; Amino Acids; Animals; Gastrointestinal Hormones; Glucagon; Glucose; Humans; Hypoglycemia; Liver; Liver Cirrhosis; Parasympathetic Nervous System; Somatostatin; Sympathetic Nervous System | 1977 |
[Circulating types of human glucagon (author's transl)].
Topics: Antibody Specificity; Antigens; Glucagon; Humans; Kidney Failure, Chronic; Liver Cirrhosis; Molecular Weight; Pancreatic Neoplasms | 1978 |
Glucagon, cirrhosis, and the pancreas.
Topics: Animals; Dogs; Glucagon; Humans; Liver Cirrhosis; Pancreas; Rats | 1979 |
Hyperglucagonemia in liver cirrhosis with portal-systemic venous anastomoses: responses of plasma glucagon and gastric inhibitory polypeptide to oral or intravenous glucose in cirrhotics with normal or elevated fasting plasma glucose levels.
Topics: Administration, Oral; Blood Glucose; Fasting; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucose; Humans; Injections, Intravenous; Insulin; Liver Cirrhosis; Portacaval Shunt, Surgical | 1979 |
Insulin and glucagon levels in liver cirrhosis. Relationship with plasma amino acid imbalance of chronic hepatic encephalopathy.
Topics: Adult; Aged; Amino Acids; Amino Acids, Branched-Chain; Female; Glucagon; Gluconeogenesis; Hepatic Encephalopathy; Homeostasis; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Tryptophan | 1979 |
Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosis.
Topics: Adult; Glucagon; Glucose Tolerance Test; Humans; Insulin; Kinetics; Liver Cirrhosis; Middle Aged; Portal Vein; Veins | 1979 |
The glucoregulatory hormones in cirrhosis of the liver.
Topics: C-Peptide; Carbohydrate Metabolism; Glucagon; Gluconeogenesis; Glucose; Humans; Hyperinsulinism; Insulin; Liver Cirrhosis; Pancreas | 1979 |
Oral glucose in cirrhotics. Effects on plasma aminoacid patterns and the role of insulin and glucagon.
Topics: Adult; Aged; Amino Acids; Blood Glucose; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Kinetics; Liver Cirrhosis; Middle Aged | 1979 |
Hyperglucagonaemia and necrolytic migratory erythema in cirrhosis--possible pseudoglucagonoma syndrome.
Topics: Adolescent; Erythema; Glucagon; Humans; Liver Cirrhosis; Male; Skin; Syndrome | 1979 |
Glucagon metabolism in normal subjects and in cirrhotic patients before and after portasystemic venous shunt surgery.
Topics: Adult; Fasting; Female; Glucagon; Humans; Liver Circulation; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Portal Vein | 1979 |
Glucose, insulin and somatostatin infusion for the determination of insulin resistance in liver cirrhosis.
Topics: Adult; Blood Glucose; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Liver Cirrhosis; Male; Middle Aged; Somatostatin | 1979 |
Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: paired studies of pre- and post-shunted subjects.
Topics: Adult; Blood Glucose; Chromatography, Gel; Dietary Proteins; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Portacaval Shunt, Surgical; Postoperative Period | 1979 |
[Clinical studies of pancreatic endocrine function in liver cirrhosis].
Topics: Adult; Aged; C-Peptide; Female; Glucagon; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Peptides | 1977 |
[Significance of glucagon test in liver cirrhosis].
Topics: Blood Glucose; Glucagon; Glucose Tolerance Test; Humans; Liver Cirrhosis | 1977 |
[Changes in blood sugar, IRI, growth hormone and plasma glucagon induced by somatostatin in subjects with liver cirrhosis].
Topics: Aged; Blood Glucose; Glucagon; Growth Hormone; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Somatostatin | 1977 |
The effect of glucagon on free plasma amino acids in cirrhotics and healthy controls.
Topics: Amino Acids; Depression, Chemical; Glucagon; Humans; Liver Cirrhosis | 1978 |
Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.
Topics: Adult; Aged; Blood Glucose; Glucagon; Humans; Hypertension, Portal; Insulin; Kinetics; Liver Cirrhosis; Male; Middle Aged; Portacaval Shunt, Surgical | 1978 |
[Plasma glucagon responses to L-arginine in various diseases (author's transl)].
Topics: Adolescent; Adult; Aged; Arginine; Chronic Disease; Diabetes Mellitus; Glucagon; Humans; Hyperthyroidism; Kidney Failure, Chronic; Liver Cirrhosis; Middle Aged; Pancreatitis; Time Factors | 1978 |
Inability of glucagon to increase glomerular filtration rate in dogs with experimental cirrhosis and ascites.
Topics: Animals; Ascites; Dogs; Female; Glomerular Filtration Rate; Glucagon; Liver Cirrhosis; Male | 1978 |
[Effect of glucagon on serum iron and copper levels in healthy subjects and in patients with liver cirrhosis (proceedings)].
Topics: Adult; Copper; Glucagon; Humans; Iron; Liver Cirrhosis; Male | 1978 |
Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.
Topics: Alcoholism; Blood Glucose; Cholesterol; Fasting; Female; Glucagon; Humans; Hydroxymethylglutaryl CoA Reductases; Insulin; Liver Cirrhosis; Male; Middle Aged; Portacaval Shunt, Surgical; Triglycerides | 1977 |
[Glucagon test in cirrhosis of the liver (author's transl)].
Topics: Antigens; Blood Glucose; Glucagon; Humans; Insulin; Liver Cirrhosis | 1977 |
[Effect of glucagon on serum immunoreactive insulin concentration in patients with compensated liver cirrhosis].
Topics: Antigens; Female; Glucagon; Humans; Insulin; Insulin Secretion; Liver Cirrhosis; Male; Secretory Rate | 1977 |
[Comparison of tolbutamide and glucagon effects on plasma levels of free amino acids in cirrhotics (author's transl)].
Topics: Amino Acids; Glucagon; Humans; Insulin; Liver Cirrhosis; Tolbutamide | 1977 |
Glucagon: its significance in health and disease.
Topics: Diabetes Mellitus; Endocrine System Diseases; Glucagon; Insulin; Insulin Secretion; Kidney Diseases; Liver Cirrhosis; Pancreatic Neoplasms; Pancreatitis | 1976 |
Heterogeneity of plasma immunoreactive glucagon.
Topics: Animals; Diabetes Mellitus; Dogs; Ducks; Glucagon; Humans; Hypoglycemia; Immunoglobulin G; Kidney; Kidney Failure, Chronic; Liver Cirrhosis; Mice; Molecular Weight; Phlorhizin | 1976 |
[Metabolic effect of administration of glucagon and a combination of glucagon and fructose to patients with cirrhosis of the liver and to healthy subjects (author's transl)].
Topics: Fatty Acids, Nonesterified; Fructose; Glucagon; Humans; Liver; Liver Cirrhosis; Triglycerides | 1976 |
[Changes in plasma insulin and growth hormone after intravenous glucagon in hepatic cirrhosis].
Topics: Adult; Glucagon; Growth Hormone; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged | 1976 |
[Reinvestigation of hyperglycemic response to glucagon and the effect of glucagon on blood cholesterol and triglyceride concentrations. (2) Changes in liver disease (author's transl)].
Topics: Acute Disease; Blood Glucose; Cholesterol; Chronic Disease; Glucagon; Hepatitis; Humans; Insulin; Liver Cirrhosis; Liver Diseases; Triglycerides | 1976 |
[Are disturbances of small intestinal motility associated with hyperglucagonemia in patients with liver cirrhosis?].
Topics: Adult; Aged; Female; Gastrointestinal Motility; Glucagon; Humans; Intestine, Small; Liver Cirrhosis; Male; Middle Aged | 1992 |
Effects of somatostatin on renal function in cirrhosis.
Topics: Dinoprostone; Glomerular Filtration Rate; Glucagon; Humans; Kidney; Liver Cirrhosis; Renal Circulation; Somatostatin | 1992 |
Characterization of the insulin resistance in liver cirrhosis: a comparison with non-insulin dependent diabetes mellitus.
Topics: C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Erythrocytes; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Resistance; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Receptor, Insulin | 1992 |
Glucagon-independent renal hyperaemia and hyperfiltration after an oral protein load in Child A liver cirrhosis.
Topics: Dietary Proteins; Female; Glomerular Filtration Rate; Glucagon; Hepatitis; Hormones; Humans; Kidney; Liver Cirrhosis; Male; Middle Aged; Renal Circulation | 1992 |
Plasma somatostatin response to an oral mixed test meal in cirrhotic patients.
Topics: Administration, Oral; Aged; Blood Glucose; C-Peptide; Fasting; Female; Food, Formulated; Glucagon; Glucose Tolerance Test; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Somatostatin; Time Factors | 1991 |
Is hepatic glycogen content a regulator of glucagon secretion?
Topics: Adult; Aged; Blood Glucose; Fasting; Female; Glucagon; Humans; Hyperthyroidism; Liver Cirrhosis; Liver Glycogen; Male; Middle Aged; Reference Values | 1992 |
Necrolytic migratory erythema without glucagonoma: the role of dietary essential fatty acids.
Topics: Docosahexaenoic Acids; Drug Combinations; Eicosapentaenoic Acid; Erythema; Fatty Acids; Fatty Acids, Omega-3; Glucagon; Humans; Liver Cirrhosis; Male; Middle Aged; Necrosis; Zinc | 1991 |
Glucagon-induced alteration of serum bile acid level in patients with liver cirrhosis.
Topics: Bile Acids and Salts; Bucladesine; Cyclic AMP; Evaluation Studies as Topic; Female; Glucagon; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged | 1991 |
Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.
Topics: Adult; Aged; Blood Glucose; Body Constitution; Catecholamines; Energy Metabolism; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Insulin Resistance; Lipids; Liver; Liver Cirrhosis; Male; Middle Aged; Oxidation-Reduction | 1991 |
Low serum T3 and raised reverse T3 levels in hepatic cirrhosis: role of glucagon.
Topics: Adult; Aged; Blood Glucose; Female; Glucagon; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Thyroid Hormones; Triiodothyronine; Triiodothyronine, Reverse | 1991 |
Effect of glucagon on bile acid metabolism after resection of liver cancer in patients with cirrhosis.
Topics: Bile Acids and Salts; Cyclic AMP; Glucagon; Hepatectomy; Humans; Liver Cirrhosis; Liver Neoplasms | 1990 |
Stimulation of glucagon secretion by gastric inhibitory polypeptide in patients with hepatic cirrhosis and hyperglucagonemia.
Topics: Blood Glucose; Food; Gastric Inhibitory Polypeptide; Glucagon; Humans; Insulin; Kinetics; Liver Cirrhosis; Portacaval Shunt, Surgical; Triglycerides | 1991 |
Glucose and fat metabolism during short-term starvation in cirrhosis.
Topics: Adult; Aged; Calorimetry, Indirect; Epinephrine; Fasting; Fatty Acids; Female; Glucagon; Glucose; Humans; Insulin; Lipid Metabolism; Liver Cirrhosis; Male; Middle Aged; Norepinephrine; Palmitates | 1991 |
[The effect of glucagon on portal hemodynamics in patients with liver cirrhosis].
Topics: Blood Flow Velocity; Glucagon; Humans; Hypertension, Portal; Liver Cirrhosis; Portal System; Regional Blood Flow | 1991 |
[Effect of glucagon on bile acid after hepatectomy in patients with hepatocellular carcinoma associated with cirrhosis].
Topics: Bile Acids and Salts; Carcinoma, Hepatocellular; Glucagon; Hepatectomy; Humans; Injections, Intravenous; Liver Cirrhosis; Liver Neoplasms; Postoperative Period | 1990 |
Effects of branched-chain amino acids on nitrogen metabolism in patients with cirrhosis.
Topics: Amino Acids; Amino Acids, Branched-Chain; Ammonia; Glucagon; Humans; Insulin; Leucine; Liver Cirrhosis; Methylhistidines; Nitrogen | 1990 |
The effect of non-protein liquid meals on the hepatic venous pressure gradient in patients with cirrhosis.
Topics: Adult; Aged; Alcoholism; Dietary Proteins; Female; Glucagon; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Venous Pressure | 1990 |
Increased gastric PGE2 biosynthesis in cirrhotic patients with gastric vascular ectasia.
Topics: Adult; Aged; Arginine Vasopressin; Biopsy; Chromatography, High Pressure Liquid; Dilatation, Pathologic; Dinoprostone; Female; Gastric Mucosa; Glucagon; Humans; Liver Cirrhosis; Male; Middle Aged; Norepinephrine; Pyloric Antrum; Radioimmunoassay; Secretin | 1990 |
Effects of intravenous amino acid infusion and dietary proteins on kidney function in cirrhosis.
Topics: Amino Acids; Blood Flow Velocity; Blood Pressure; Dietary Proteins; Female; Glomerular Filtration Rate; Glucagon; Humans; Infusions, Intravenous; Kidney; Liver Cirrhosis; Male; Middle Aged; Osmolar Concentration; Renal Circulation | 1990 |
Hemodynamic effects of glucagon in portal hypertension.
Topics: Azygos Vein; Female; Glucagon; Hemodynamics; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Regional Blood Flow; Splanchnic Circulation; Vasodilation; Venous Pressure | 1990 |
Hormonal and metabolic changes during exercise in cirrhotic patients.
Topics: Age Factors; Blood Glucose; Calorimetry, Indirect; Carnitine; Catecholamines; Eating; Exercise; Fatty Acids, Nonesterified; Glucagon; Glycerol; Humans; Insulin; Lactates; Liver Cirrhosis; Male; Middle Aged; Oxygen Consumption; Respiratory Transport; Rest | 1990 |
[The implication of hyperglucagonemia and -insulinemia in liver cirrhotics].
Topics: Adult; Female; Glucagon; Humans; Hyperinsulinism; Insulin; Liver Cirrhosis; Male; Middle Aged | 1989 |
[Plasma lipids, insulin, C-peptide, and glucagon levels in cirrhosis: personal observations].
Topics: Adult; Aged; C-Peptide; Female; Glucagon; Humans; Insulin; Lipids; Liver Cirrhosis; Male; Middle Aged | 1989 |
Insulin and glucagon degradation in liver are not affected by hepatic cirrhosis.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Liver; Liver Cirrhosis; Male; Middle Aged | 1989 |
C-peptide in non-alcoholic cirrhosis and hepatocellular carcinoma.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Carcinoma, Hepatocellular; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged | 1988 |
Circulating somatostatin concentrations in healthy and cirrhotic subjects.
Topics: Adult; Blood Glucose; Female; Glucagon; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Somatostatin; Time Factors | 1986 |
The influence of a long-acting somatostatin analogue on splanchnic haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis.
Topics: Adolescent; Adult; Aged; Blood Glucose; Blood Pressure; Esophageal and Gastric Varices; Female; Glucagon; Hemodynamics; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Octreotide; Somatostatin; Splanchnic Circulation | 1986 |
Glucagon and glucose tolerance in liver cirrhosis.
Topics: Adult; Blood Glucose; Glucagon; Glucose Tolerance Test; Humans; Infusions, Intravenous; Insulin; Liver Cirrhosis; Male; Middle Aged; Somatostatin | 1988 |
[Behavior of circulating somatostatin in cirrhotic subjects: correlation with hepatic function].
Topics: Glucagon; Humans; Insulin; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Somatostatin | 1988 |
Gluconeogenesis from nitrogen precursors and hyperammonemia of cirrhosis: is there a cause-effect relationship?
Topics: Ammonia; Glucagon; Gluconeogenesis; Humans; Liver Cirrhosis; Nitrogen | 1989 |
Characterization of hepatic hemodynamics in cirrhotics and non-cirrhotics. Effect of glucagon infusion.
Topics: Adult; Blood Glucose; Female; Glucagon; Hemodynamics; Hepatitis; Humans; Infusions, Intravenous; Liver; Liver Cirrhosis; Male; Middle Aged; Oxygen Consumption | 1989 |
[Measurement of portal blood flow and effective hepatic circulation in liver cirrhosis--influence of glucagon].
Topics: Female; Glucagon; Humans; Indocyanine Green; Liver Circulation; Liver Cirrhosis; Male; Portal System; Regional Blood Flow; Rheology | 1986 |
Secretion of glucagon in liver cell carcinoma.
Topics: Aged; Animals; Arginine; Blood Glucose; Carcinoma, Hepatocellular; Dogs; Glucagon; Humans; Insulin; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Secretory Rate; Tissue Extracts | 1985 |
Responses of plasma cyclic AMP, serum immunoreactive insulin, C-peptide immunoreactivity and blood sugar levels to glucagon in patients with liver diseases.
Topics: Adult; Blood Glucose; C-Peptide; Cyclic AMP; Female; Glucagon; Hepatitis, Viral, Human; Humans; Insulin; Kinetics; Liver Cirrhosis; Liver Diseases; Male; Middle Aged | 1985 |
[Effects of intravenous perfusion of glucagon on plasma concentrations of glucose, insulin and cyclic AMP in patients with hepatic cirrhosis].
Topics: Blood Glucose; Cyclic AMP; Female; Glucagon; Humans; Infusions, Parenteral; Insulin; Liver Cirrhosis; Male; Middle Aged | 1985 |
[Clinical significance of plasma c-AMP response to glucagon for the assessment of the prognosis in liver cirrhosis and hepatocellular carcinoma].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cyclic AMP; Female; Glucagon; Humans; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Prognosis | 1986 |
[The cyclic AMP, insulin and glucose responses to glucagon stimulation in patients with liver cirrhosis according to the stage of development ].
Topics: Adult; Blood Glucose; Cyclic AMP; Female; Glucagon; Humans; Insulin; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged | 1986 |
[Glucose homeostasis in the cirrhotic liver. Diagnostic and prognostic value of the intravenous glucagon double test].
Topics: Glucagon; Glucose; Homeostasis; Humans; Injections, Intravenous; Liver Cirrhosis; Prognosis | 1988 |
[Clinical evaluation of ursodeoxycholic acid. Glucagon tolerance test in patients with chronic liver disease].
Topics: Bile Acids and Salts; Chronic Disease; Deoxycholic Acid; Glucagon; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Predictive Value of Tests; Ursodeoxycholic Acid | 1988 |
[Pancreatic polypeptide response to oral glucose load in patients with liver cirrhosis--interrelationship between PP and other pancreatic endocrine hormones].
Topics: C-Peptide; Diabetes Complications; Diabetes Mellitus; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Secretion; Liver Cirrhosis; Middle Aged; Pancreatic Hormones; Pancreatic Polypeptide; Radioimmunoassay | 1988 |
Hyperglucagonism and glucagon resistance in cirrhosis. Paradoxical effect of propranolol on plasma glucagon levels.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Drug Resistance; Female; Glucagon; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Propranolol | 1988 |
Elevation of plasma glucagon-like immunoreactivity (GLI) in patients with liver cirrhosis.
Topics: Adult; Aged; Female; Glucagon; Glucagon-Like Peptides; Glucose Tolerance Test; Humans; Liver Cirrhosis; Male; Middle Aged; Peptides | 1986 |
Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver.
Topics: Adult; Blood Glucose; Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Resistance; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Time Factors | 1986 |
[Behavior of blood ammonia, insulin, glucagon, renin and prolactin during propranolol therapy in cirrhosis patients with portal hypertension].
Topics: Adult; Aged; Ammonia; Dose-Response Relationship, Drug; Drug Evaluation; Female; Glucagon; Humans; Hypertension, Portal; Insulin; Liver Cirrhosis; Male; Middle Aged; Prolactin; Propranolol; Renin; Time Factors | 1986 |
[Systemic hyperdynamic circulation and serum hormone concentrations in portal hypertension].
Topics: Adult; Aldosterone; Female; Glucagon; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Renin | 1986 |
Effects of food intake and various extrinsic hormones on portal blood flow in patients with liver cirrhosis demonstrated by pulsed Doppler with the Octoson.
Topics: Adult; Aged; Female; Food; Gastrins; Glucagon; Hormones; Humans; Insulin; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Prostaglandins E; Secretin; Ultrasonics; Vasopressins | 1986 |
[Mechanism of hyperdynamic systemic circulation in cirrhotic patients].
Topics: Catecholamines; Glucagon; Hemodynamics; Humans; Liver Cirrhosis; Plasma Volume | 1986 |
Elevated plasma ammonia level in hepatic cirrhosis: role of glucagon.
Topics: Adult; Ammonia; Dietary Proteins; Fasting; Glucagon; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged | 1985 |
Changes in plasma amino acids during the oral glucose tolerance test and the effect of these changes on hepatic encephalopathy.
Topics: Adult; Aged; Amino Acids; Blood Glucose; Female; Glucagon; Glucose Tolerance Test; Hepatic Encephalopathy; Humans; Indocyanine Green; Insulin; Liver Cirrhosis; Male; Middle Aged | 1985 |
Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Eating; Female; Glucagon; Humans; Insulin; Islets of Langerhans; Liver Cirrhosis; Male; Middle Aged | 1985 |
[Changes in carbohydrate metabolism in hepatic cirrhosis].
Topics: Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Liver Cirrhosis; Male | 1985 |
Effects of secretin on insulin and glucagon in portal and peripheral blood in man.
Topics: Blood; Glucagon; Glucose; Humans; Insulin; Liver Cirrhosis; Neoplasms; Portal Vein; Secretin | 1966 |
[Glycoregulation disorders in cirrhosis patients].
Topics: Adult; Aged; Blood Glucose; Carbohydrate Metabolism; Female; Glucagon; Humans; Liver Cirrhosis; Male; Middle Aged | 1966 |
[Hypoglycemia and primary liver cancer. Hormone levels. Action of diazoxide].
Topics: Adult; Carcinoma, Hepatocellular; Diazoxide; Glucagon; Growth Hormone; Humans; Hypoglycemia; Insulin; Liver Cirrhosis; Liver Neoplasms; Male | 1967 |
Diagnostic use of glucagon-induced insulin response. Studies in patients with insulinoma or other hypoglycemic conditions.
Topics: Adenoma, Islet Cell; Adult; Aged; Blood Glucose; Carcinoma, Hepatocellular; Child; Diagnosis, Differential; Ethanol; Female; Glucagon; Humans; Hypoglycemia; Injections, Intravenous; Insulin; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Stimulation, Chemical; Tolbutamide | 1974 |
[The pancreatic beta-cell in the field of current diabetology].
Topics: Blood Glucose; Cyclic AMP; Diabetes Mellitus; Glucagon; Glucose Tolerance Test; Glyburide; Growth Hormone; Humans; Hyperinsulinism; Insulin; Insulin Secretion; Liver Cirrhosis; Pancreas; Secretory Rate; Theophylline | 1974 |
[Effect of glucagon on glucose and nonesterified fatty acids in chronic hepatic disease (author's transl)].
Topics: Blood Glucose; Chronic Disease; Fatty Acids, Nonesterified; Glucagon; Hepatitis; Humans; Liver; Liver Cirrhosis | 1974 |
A study of carbohydrate metabolism in postnecrotic cirrhosis liver.
Topics: Adult; Carbohydrate Metabolism; Fatty Acids, Nonesterified; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Tolbutamide | 1974 |
[Histologic diagnosis of glucogenosis type IV (amylopectinosis) (author's transl)].
Topics: Amylopectin; Biopsy, Needle; Child, Preschool; Glucagon; Glucosyltransferases; Glycogen Storage Disease; Glycolysis; Humans; Liver Cirrhosis; Liver Diseases; Male; Myocardium; Polysaccharides; Syndrome | 1974 |
Carbohydrate metabolism in alcohol-induced fatty liver. Evidence for an abnormal insulin response to glucagon in alcoholic liver disease.
Topics: Adult; Aged; Alcoholism; Blood Glucose; Fatty Liver; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged | 1973 |
Elevated plasma glucagon levels in cirrhosis of the liver.
Topics: Adult; Aged; Antigens; Arginine; Blood Glucose; Female; Glucagon; Glucose Tolerance Test; Humans; Iliac Vein; Insulin; Insulin Secretion; Liver Cirrhosis; Male; Mesenteric Veins; Middle Aged; Nitrogen; Portacaval Shunt, Surgical; Radioimmunoassay; Stimulation, Chemical | 1973 |
[Method for hemodynamic and metabolic evaluation of patients needing intensive therapy. In reference to the experiences of Dr. Siegel and coworkers].
Topics: Glucagon; Heart Failure; Hemodynamics; Humans; Intensive Care Units; Isoproterenol; Liver Cirrhosis; Metabolism; Myocardial Infarction; Shock | 1973 |
[Behavior of the blood sugar after subintrant doses of glucagon as a possible test of hepatic function].
Topics: Blood Glucose; Cholestasis; Glucagon; Hepatitis; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests | 1973 |
Letter: Cirrhosis, glucagon and pancreatitis.
Topics: Glucagon; Humans; Liver Cirrhosis; Pancreatitis | 1974 |
Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting.
Topics: Adolescent; Adult; Aged; Alanine; Alcoholism; Amino Acids; Ammonia; Blood Glucose; Esophageal and Gastric Varices; Fatty Liver; Glucagon; Humans; Insulin; Liver; Liver Circulation; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Portacaval Shunt, Surgical | 1974 |
The behaviour of insulinaemia in patients ith liver cirrhosis after intravenous administration of glucose, tolbutamide and glucagon.
Topics: Adult; Blood Glucose; Female; Glucagon; Glucose; Humans; Injections, Intravenous; Insulin; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Tolbutamide | 1971 |
[Glucagon-induced hyperglycemia as a measure of liver function].
Topics: Adolescent; Adult; Aged; Blood Glucose; Female; Galactose; Glucagon; Half-Life; Humans; Hyperglycemia; Injections, Intravenous; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Serum Albumin | 1971 |
Effect of glucagon infusion on cardiovascular function in critically ill surgical patients.
Topics: Arrhythmias, Cardiac; Cardiac Output; Digitalis Glycosides; Glucagon; Heart; Infusions, Parenteral; Liver Cirrhosis; Oxygen Consumption; Surgical Procedures, Operative | 1969 |
The effect of glucagon infusion on cardiovascular function in the critically ill.
Topics: Adult; Blood Pressure; Cardiac Output; Cardiovascular System; Digitalis Glycosides; Drug Synergism; Female; Glucagon; Heart Rate; Humans; Hypotension; Infections; Isoproterenol; Liver Cirrhosis; Oxygen Consumption; Postoperative Care; Preoperative Care | 1970 |
The double glucagon test, a new liver function test.
Topics: Cholelithiasis; Cholestasis; Diabetes Mellitus; Diagnosis, Differential; Glucagon; Hepatitis A; Humans; Liver Cirrhosis; Liver Function Tests; Methods | 1971 |
Regulation of insulin secretion by the intestinal hormone, secretin: studies in man via transumbilical portal vein catheterization.
Topics: Angiography; Blood Glucose; Carcinoma; Catheterization; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hypertension, Portal; Injections, Intravenous; Insulin; Insulin Secretion; Intestinal Secretions; Liver Cirrhosis; Liver Neoplasms; Lymphoma; Portal Vein; Secretin | 1968 |
Carbohydrate metabolism studies in cirrhosis of the liver.
Topics: Adult; Aged; Blood Glucose; Carbohydrate Metabolism; Diabetes Complications; Female; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin; Kidney Failure, Chronic; Liver Cirrhosis; Male; Middle Aged; Potassium Deficiency; Sulfobromophthalein; Tolbutamide; Uremia | 1968 |
[Evaluation of liver function by means of the glucagon test].
Topics: Adolescent; Adult; Aged; Blood Glucose; Catheterization; Cholestasis; Fatty Liver; Glucagon; Hepatic Veins; Hepatitis A; Humans; Hyperbilirubinemia; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Glycogen; Middle Aged | 1968 |
[Glucagon and lipid metabolism. II. Effects of glucagon on the blood level of lipoproteins and on the behavior of the Kunkel reaction to phenol. (Statistical observations on the biologic significance of the turbidimetric test)].
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Diabetes Mellitus; Female; Glucagon; Humans; In Vitro Techniques; Lipoproteins; Liver Cirrhosis; Male; Middle Aged; Phenols | 1965 |
[Glucagon and lipid metabolism. 3. Modifications of the total blood lipids, phospholipids and hematic neutral fats due to glucagon stimulation].
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Diabetes Mellitus; Female; Glucagon; Glycerides; Humans; In Vitro Techniques; Lipid Metabolism; Liver Cirrhosis; Male; Middle Aged; Phospholipids | 1965 |
[Glucagon and lipid metabolism. I. Changes in total blood cholesterol and in its fractions due to glucagon stimulation].
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Cholesterol; Diabetes Mellitus; Female; Glucagon; Humans; In Vitro Techniques; Liver Cirrhosis; Male; Middle Aged | 1965 |
The effects of glucagon on systemic and hepatosplanchnic haemodynamics and on net peripheral and hepatosplanchnic balance of glucose, lactic and pyruvic acids in normal subjects and cirrhotics.
Topics: Adult; Blood; Blood Circulation; Blood Glucose; Femoral Artery; Femoral Vein; Glucagon; Humans; Lactates; Liver Circulation; Liver Cirrhosis; Pyruvates | 1966 |